Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Henderson Molly

SEC-identified person · CIK 1363812 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Phathom Pharmaceuticals, Inc. PHAT CFO and CBO filed 2022 - 2025
Urogen Pharma Ltd. URGN Chief Financial Officer filed 2020 - 2022
Ayala Pharmaceuticals, Inc. ADXS Executive Vice President & CFO filed 2018 - 2020
Lion Biotechnologies, Inc. N/A Chief Financial Officer filed 2015 - 2016
Virtualscopics, Inc. vscp Director · Chief Financial Officer filed 2006 - 2013

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.